These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8178668)

  • 61. Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method.
    Sahai S; Arora RC; Meltzer HY
    Psychiatry Res; 1981 Oct; 5(2):111-4. PubMed ID: 6945605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P; Friedl W
    Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low platelet monoamine oxidase activity in human alcoholics.
    Wiberg A; Gottfries CG; Oreland L
    Med Biol; 1977 Jun; 55(3):181-6. PubMed ID: 895216
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Platelet monoamine oxidase-B activity in type 1 alcohol-dependent subjects in sustained full remission.
    Berggren U; Eriksson M; Fahlke C; Blennow K; Sundkler A; Balldin J
    Alcohol Alcohol; 2002; 37(4):340-3. PubMed ID: 12107035
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Platelet and plasma amine oxidase activity in alcoholic individuals.
    Major LF; Murphy DL
    Br J Psychiatry; 1978 Jun; 132():548-54. PubMed ID: 656722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet monoamine oxidase activity in patients with panic disorder.
    Gorman J; Liebowitz MR; Fyer AJ; Levitt M; Baron M; Davies S; Klein DF
    Biol Psychiatry; 1985 Aug; 20(8):852-7. PubMed ID: 4027301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A commingling analysis of platelet monoamine oxidase activity.
    Rice J; McGuffin P; Shaskan EG
    Psychiatry Res; 1982 Dec; 7(3):325-35. PubMed ID: 6962440
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder.
    Verkes RJ; Van der Mast RC; Kerkhof AJ; Fekkes D; Hengeveld MW; Tuyl JP; Van Kempen GM
    Biol Psychiatry; 1998 May; 43(10):740-6. PubMed ID: 9606528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
    Sullivan J; Stanfield CN; Dackis C
    Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Platelet monoamine oxidase activity in type 1 and type 2 alcoholism.
    von Knorring AL; Hallman J; von Knorring L; Oreland L
    Alcohol Alcohol; 1991; 26(4):409-16. PubMed ID: 1760052
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Platelet MAO, personality and response to lithium prophylaxis.
    Abou-Saleh MT
    J Affect Disord; 1983 Feb; 5(1):55-65. PubMed ID: 6220045
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psychiatric vulnerability, monoamine oxidase, and the average evoked potential.
    Haier RJ; Buchsbaum MS; Murphy DL; Gottesman II; Coursey RD
    Arch Gen Psychiatry; 1980 Mar; 37(3):340-5. PubMed ID: 7362421
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monoamine oxidase activity in blood platelets of migraine patients.
    Caramona MM; Cotrim MD; Ribeiro CF; Macedo T
    J Neural Transm Suppl; 1990; 32():161-4. PubMed ID: 2089084
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Platelet monoaminooxidase activity and behavioural characteristics in humans.
    Castrogiovanni P; Maremmani I; Bongioanni P; Marazziti D
    Neuropsychobiology; 1990-1991; 23(4):173-6. PubMed ID: 2130285
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical correlates of tricyclic antidepressant-mediated inhibition of platelet monoamine oxidase.
    Sullivan JL; Zung WW; Stanfield CN; Cavenar JO
    Biol Psychiatry; 1978 Jun; 13(3):399-407. PubMed ID: 667237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.